- Home
- SBFM vs IBG Comparison
SBFM vs IBG Comparison
Compare SBFM & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- IBG
- Stock Information
- Founded
- SBFM 2006
- IBG 2018
- Country
- SBFM United States
- IBG Australia
- Employees
- SBFM N/A
- IBG N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- SBFM Health Care
- IBG Consumer Staples
- Exchange
- SBFM Nasdaq
- IBG Nasdaq
- Market Cap
- SBFM 6.7M
- IBG 7.8M
- IPO Year
- SBFM N/A
- IBG 2024
- Fundamental
- Price
- SBFM $1.67
- IBG $3.33
- Analyst Decision
- SBFM Strong Buy
- IBG Strong Buy
- Analyst Count
- SBFM 1
- IBG 1
- Target Price
- SBFM $15.00
- IBG N/A
- AVG Volume (30 Days)
- SBFM 62.2K
- IBG 6.0M
- Earning Date
- SBFM 11-04-2025
- IBG 11-15-2025
- Dividend Yield
- SBFM N/A
- IBG N/A
- EPS Growth
- SBFM N/A
- IBG N/A
- EPS
- SBFM N/A
- IBG N/A
- Revenue
- SBFM $36,341,741.00
- IBG $2,931,243.00
- Revenue This Year
- SBFM $32.20
- IBG N/A
- Revenue Next Year
- SBFM $32.74
- IBG N/A
- P/E Ratio
- SBFM N/A
- IBG N/A
- Revenue Growth
- SBFM 19.22
- IBG N/A
- 52 Week Low
- SBFM $1.17
- IBG $1.48
- 52 Week High
- SBFM $3.90
- IBG $11.50
- Technical
- Relative Strength Index (RSI)
- SBFM 67.82
- IBG 62.66
- Support Level
- SBFM $1.50
- IBG $2.16
- Resistance Level
- SBFM $1.67
- IBG $5.38
- Average True Range (ATR)
- SBFM 0.08
- IBG 0.72
- MACD
- SBFM 0.01
- IBG 0.10
- Stochastic Oscillator
- SBFM 73.44
- IBG 48.70
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.